Key facts
- This page summarizes Jayne B. Hart's Form 4 filing for MYRIAD GENETICS INC (MYGN).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 02 Mar 2023, 15:06.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Additional SEC filing notes
Section 16 status
Jayne B. Hart is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
The holdings for the Reporting Person include one additional share that was acquired on November 30, 2022 under the Myriad Genetics, Inc. 2012 Amended and Restated Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
SEC remarks
This "Exit" Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving in the role as the Company's Chief People Officer, effective March 1, 2023, and therefore is no longer subject to Section 16 reporting.